SKYSTAR BIO-PHARMACEUTICAL CO Current Foreign Tax Expense (Benefit)
SKYSTAR BIO-PHARMACEUTICAL CO reported Current Foreign Tax Expense (Benefit) of $1.02 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO current foreign tax expense (benefit) for the quarter ending 2014-09-30 was $1.02M, a 8.92% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO current foreign tax expense (benefit) for the quarter ending 2014-06-30 was $653.09K, a 6.27% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO current foreign tax expense (benefit) for the quarter ending 2014-03-31 was $472.41K, a 47.04% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO current foreign tax expense (benefit) for the quarter ending 2013-12-31 was $621.30K.
- SKYSTAR BIO-PHARMACEUTICAL CO current foreign tax expense (benefit) for fiscal 2013 was $2.76M, a 27.34% increase from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO current foreign tax expense (benefit) for fiscal 2012 was $2.17M.
| Period end | Current Foreign Tax Expense (Benefit) 3 month | Current Foreign Tax Expense (Benefit) 6 month | Current Foreign Tax Expense (Benefit) 9 month | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2014-09-30 | $1.02M 10-Q · filed 2014-11-14 | $1.67M derived: sum of 2 quarters · filed 2014-11-14 | $2.15M 10-Q · filed 2014-11-14 | $2.77M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $653.09K 10-Q · filed 2014-08-14 | $1.13M 10-Q · filed 2014-08-14 | $1.75M derived: sum of 3 quarters · filed 2014-08-14 | $2.87M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $472.41K 10-Q · filed 2014-05-15 | $1.09M derived: sum of 2 quarters · filed 2014-05-15 | $2.22M derived: sum of 3 quarters · filed 2014-11-14 | $2.91M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $621.30K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.74M derived: sum of 2 quarters · filed 2014-11-14 | $2.44M derived: sum of 3 quarters · filed 2014-11-14 | $2.76M 10-K · filed 2014-03-31 |
| 2013-09-30 | $1.12M 10-Q · filed 2014-11-14 | $1.82M derived: sum of 2 quarters · filed 2014-11-14 | $2.14M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $696.76K 10-Q · filed 2014-08-14 | $1.02M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $321.28K 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | $2.17M 10-K · filed 2014-03-31 |